Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
about
Identification and characterization of unique proline-rich peptides binding to the mitochondrial fission protein hFis1Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library designRecent Advances Toward the Discovery of Drug-Like Peptides De novoSynthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptorIn vitro methods for peptide display and their applications.Mechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcMDiscovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2.In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors.Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides.A Cleavable Scaffold Strategy for the Synthesis of One-Bead One-Compound Cyclic Peptoid Libraries That Can Be Sequenced By Tandem Mass Spectrometry.Genetically encoded libraries of nonstandard peptides.mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands.Fluorescent mu selective opioid ligands from a mixture based cyclic peptide library.In vitro selection of a photo-responsive peptide aptamer using ribosome display.Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactionsTechnologies for the synthesis of mRNA-encoding libraries and discovery of bioactive natural product-inspired non-traditional macrocyclic peptides.Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonistDevelopment of Next-Generation Peptide Binders Using In vitro Display Technologies and Their Potential Applications.Cyclic peptides as therapeutic agents and biochemical tools.Methods for the creation of cyclic Peptide libraries for use in lead discovery.Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues.Preferential germline usage and VH/VL pairing observed in human antibodies selected by mRNA display.In Vitro Selection Combined with Ribosomal Translation Containing Non-proteinogenic Amino Acids.Directed Evolution of Scanning Unnatural-Protease-Resistant (SUPR) Peptides for in Vivo ApplicationsExpansion of the aptamer library from a "natural soup" to an "unnatural soup".Designer protein delivery: From natural to engineered affinity-controlled release systems.Cell-permeable bicyclic peptide inhibitors against intracellular proteins.N-Methyl scanning mutagenesis generates protease-resistant G protein ligands with improved affinity and selectivityBioinspired strategy for the ribosomal synthesis of thioether-bridged macrocyclic peptides in bacteria.Serum stable natural peptides designed by mRNA display.Expanding molecular modeling and design tools to non-natural sidechains.Enzymatic cyclisation of peptides with a transglutaminase.Directed Evolution of Glycopeptides Using mRNA Display.An affinity capture involved enzymatic assay for thrombin by using peptide aptamers as affinity ligands on magnetic beads.Ribosomal incorporation of backbone modified amino acids via an editing-deficient aminoacyl-tRNA synthetase.Exploitation of the Ornithine Effect Enhances Characterization of Stapled and Cyclic Peptides.Cyclic and Lasso Peptides: Sequence Determination, Topology Analysis, and Rotaxane Formation.Non-competitive cyclic peptides for targeting enzyme-substrate complexes.Stereoselective Formation of Chiral MetallopeptidesCell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library
P2860
Q24311781-1A165728-A0A3-4FF5-9F92-1E7B97065C79Q24594140-00CC08EE-DDE1-4268-B49B-AB5A7632563DQ26770535-BA006E24-45F2-4918-9271-391E03B9C223Q33317443-E55A9F7D-F5D0-42F3-8B50-4C81EC32EA46Q33917861-3CCD66D1-8583-4D54-80D8-A223DCF9FF56Q33951197-66317C0E-A4A3-4FBB-B763-8A7AE456FB38Q34177958-C76D86E8-912E-43D9-B06D-B435715F84B5Q34201330-4865B20F-E0A8-439F-9ADA-F19317FFA1D2Q34227953-739378FD-F7CF-4653-8AE4-F622BB60471AQ34318128-9D7E5BB0-7614-49C4-BE21-5BBECDA3A995Q34457705-B3B8379F-2A21-4D1D-BC41-ED9F69A49CDFQ34459997-5DCA947E-236B-4449-B3E9-6881AB4A3562Q34461552-D946A1C1-28AD-4E93-A74F-B402626343A1Q34466593-9AE8B2FF-1EA0-4E98-A15A-4FD609908CA6Q34522767-933B466E-19CD-4A41-97EE-9B6C09B2D31AQ34626861-AE3A4E12-8075-4146-AB2E-81F560E123F2Q34832185-1947D7E8-0B61-47C9-96F9-840B21D13A77Q34892359-525C3058-566C-416D-95AB-7D5EB4435929Q35015231-56D6A541-5430-4DBE-B7A6-FE232CC340FCQ35542409-142E7D08-F948-48D4-B65C-777BA512E3F9Q35661360-27895E1F-DF25-4BD7-8F90-4262CE4CE518Q35763923-D1C6F29E-861C-42D8-8213-8A7B5384E115Q35896248-B7154F73-E0B7-4699-90B8-EBC751F7B6B8Q36088057-072A8E37-5C06-4664-A1F4-E5CAA7B56493Q38071194-5931E31D-9CD5-4E8C-85C2-547377C486E5Q38293159-219A4FDA-FAAE-4369-A9ED-5444707AA316Q38980364-9119C663-44D2-488F-BDBC-8336FEFE7A74Q42399941-314DBE3F-2EFF-4190-A6A0-95DCFDC9F314Q42546666-B28903AD-F8CB-47AE-8C18-BCCE84044582Q42905730-EBEBAA32-8851-4EE1-98F9-BAB02603875DQ43745380-6A532159-E302-4DD5-A0B8-A51C8A350160Q46258943-05DEA3FA-A5B3-418F-9AE8-8FA252CE8F26Q47765958-87C48CFE-25FA-4D20-8897-C3C05B439E1CQ47956281-9714783D-1007-4212-8146-5659FA09D81BQ48171005-B6C97C0E-E2B3-495F-BB3D-9DDF3459C5CEQ50881656-1ED44D0D-8C15-4277-A0AD-2EBC3D8467A0Q52592311-4748865F-CF3F-4EF9-9076-F9D77BDD29B7Q55083155-B9BBBB69-2CAE-4F91-9D80-DF2FAF293038Q58571759-246A1074-9A59-4EC3-88CF-661DD7050456Q58698975-F977BF28-3098-4B29-A3E1-CD4ED1E0653D
P2860
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@en
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@nl
type
label
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@en
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@nl
prefLabel
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@en
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@nl
P2093
P2860
P356
P1433
P1476
Design of cyclic peptides that bind protein surfaces with antibody-like affinity.
@en
P2093
Richard W Roberts
Ryan J Austin
Stephen Fiacco
Steven W Millward
P2860
P304
P356
10.1021/CB7001126
P577
2007-09-01T00:00:00Z